by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Dry Springs Pharmacy Warning Letter Details

Warning Letter

Dry Springs Pharmacy

Hong Kong SAR China

Issue DateApril 01, 2026

FEI NumberN/A

Violations3

CountryChina

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

Notice of Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet

Dry Springs Pharmacy FDA Warning Letter, April 1, 2026